Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography

Angiology

Volumn 50, Issue 1, 1999, Pages 37-45

  Suzuki, Jun ^a   Yanagisawa, Atsuo ^a   Shigeyama, Toshiki ^a   Tsubota, Jun ^a   Yasumura, Toshiaki ^a   Shimoyama, Katsuya ^a   Ishikawa, Kyozo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN; DOXORUBICIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART MUSCLE INJURY; HUMAN; MALE; SCINTIANGIOGRAPHY;

EID: 0032902754     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000105     Document Type: Article

References (42)

1. Tan C, Etcubanas E, Wollner N, et al: Adriamycin -an antitumor antibiotic in treatment of neoplastic diseases. Cancer 32:9-17, 1973.
2. Young RC, Ozols RF, Myers CE, et al: The anthracycline antineoplastic drugs. N Engl J Med 305:139-153, 1981.
3. Lefrak EA, Pitha J, Rosenheim S, et al: A clinico-pathologic analysis of adriamycin cardiotoxicity. Cancer 32:302-314, 1973.
4. Halazum JF, Wagner HR, Gaeta JF, et al: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. Cancer 33:545-554, 1974.
5. Lenaz T: Doxorubicin cardiotoxicity. Cancer Treat Rev 3:111-120, 1976.
6. Von Hoff DD, Rozencweig M, Layard M, et al: Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med 62:200-208, 1977.
7. Bristow MR, Billingham ME, Mason JW, et al: Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62:873-879, 1978.
8. Von Hoff DD, Layard MW, Basa P, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717, 1979.
9. Praga C, Beretta G, Vigo PL, et al: Adriamycin cardiotoxicity: A survey of 1273 patients. Cancer Treat Rep 63:827-834, 1979.
10. Goorin AM, Borow KM, Goldman A, et al: Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children. Cancer 47:2810-2816, 1981.
11. 2: Evidence for enhanced toxicity with multiagent chemotherapy. Am J Hematol 36:217-218, 1991.
12. Minow RA, Benjamin RS, Gottlieb JA: Adriamycin (NSC-123127) cardiomyopathy - an overview with determination of risk factors. Cancer Chemother Rep 6:195-201, 1975.
13. Bender KS, Shematek JP, Leventhal BG, et al: QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr 105:442-444, 1984.
14. Schwartz CL, Hobbie WL, Truesdell S, et al: Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J Clin Oncol 11:1906-1910, 1993.
15. Lewis AB, Pilkington R, Takahashi M, et al: Echocardiographic assessment of anthracycline cardiotoxicity in children. Med Pediatr Oncol 5:167-175, 1978.
16. Bloom KR, Bini RM, Williams CM, et al: Echocardiography in adriamycin cardiotoxicity. Cancer 41:1265-1269, 1978.
17. Weesner KM, Bledsoe M, Chauvenet A, et al: Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 68:435-438, 1991.
18. Marchandise B, Schroeder E, Bosly A, et al: Early detection of doxorubicin cardiotoxicity: Interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 118:92-98, 1989.
19. Bu'Lock FA, Mott MG, Oakhill A, et al: Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology. Br Heart J 73:340, 1995.
20. Ritchie JL, Singer JW, Thorning D, et al: Anthracycline cardiotoxicity: Clinical and pathological outcomes assessed by radionuclide ejection fraction. Cancer 46:1109-1116, 1980.
21. Schwartz RG, McKenzie WB, Alexander J, et al: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 82:1109, 1987.
22. Piver MS, Marchetti DL, Parthasarathy KL, et al: Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography. Cancer 56:76-80, 1985.
23. Parmentier S, Melin JA, Piret L, et al: Assessment of left ventricular diastolic function in patients receiving anthracycline therapy. Eur J Nucl Med 13:563-567, 1988.
24. Ganz WI, Sridhar KS, Forness TJ: Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate. Am J Clin Oncol 16:109-112, 1993.
25. Bristow MR, Mason JW, Billingham ME, et al: Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88:168-175, 1978.
26. Ewer MS, Ali MK, Mackay B, et al: A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin. J Clin Oncol 2:112-117, 1984.
27. Allen A: The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 19:529-542, 1992.
28. Steinberg JS, Wasserman AG: Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity. Clin Ther 7:660-667, 1985.
29. Basser RL, Green MD: Complications of treatment. Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev 19:57-77, 1993.
30. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618, 1977.
31. Heger JJ, Weyman AE, Wann LS, et al: Cross-sectional echocardiography in acute myocardial infarction: Detection and localization of regional left ventricular asynergy. Circulation 60:531-538, 1979.
32. Spirito P, Maron BJ, Bonow RO: Noninvasive assessment of left ventricular diastolic function: Comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol 7:518-526, 1986.
33. Granier P, Esquerre JP, Tredez P, et al: Correlations between M-mode markers of left ventricular hypertrophy and radionuclide angiographic indices of left ventricular diastolic function in mild to moderate hypertension. J Hypertens 7(suppl 6):s100-s101, 1989.
34. Harrison RM, Clifton DG, Pennell TA, et al: Effect of heart rate on left ventricular diastolic transmitral flow velocity patterns assessed by Doppler echocardiography. Am J Cardiol 67:622, 1991.
35. Triulzi OM, Castini D, Ornaghi M, et al: Effects of preload reduction on mitral flow velocity pattern in normal subjects. Am J Cardiol 66:995-1001, 1990.
36. Miyaguchi K, Iwase M, Yokota M, et al: Dependency of the pulsed Doppler-derived transmitral fillings profile on the sampling site. Am Heart J 122:142-148, 1991.
37. Jaffe MW, Dewhurst AT, Otto MC, et al: Influence of Doppler sample volume location on ventricular filling velocities. Am J Cardiol 68:550-552, 1991.
38. Sakata K, Kashiro S, Hirata S, et al: Prognostic value of Doppler transmitral flow velocity patterns in acute myocardial infarction. Am J Cardiol 79:1165-1169, 1997.
39. Fukazawa R, Ogawa S, Hirayama T: Early detection of anthracycline cardiotoxicity in children with acute leukemia using exercise-based echocardiography and Doppler echocardiography. Jpn Circ J 58:625-634, 1994.
40. Harizi RC, Bianco JA, Alpert JS: Diastolic function of the heart in clinical cardiology. Arch Intern Med 148:99-109, 1988.
41. Villari B, Betocchi S, Pace L, et al: Assessment of left ventricular diastolic function. Comparison of contrast ventriculography and equilibrium radionuclide angiography. J Nucl Med 32:1849-1853, 1991.
42. Polak JF, Kemper AJ, Bianco JA, et al: Resting early peak diastolic filling rate: A sensitive index of myocardial dysfunction in patients with coronary artery disease. J Nucl Med 23:471-478, 1982.